Pharmaceuticals law management: Assessment of feasibility and effectiveness of the Universally Accessible Cheaper Medicines Act of 2008

The study aimed to assess if Republic Act No. 9502, otherwise known as Cheaper Medicines Act of 2008 has been adequately implemented in making cardiovascular medicines accessible and affordable in the Philippines. Sample respondents from the City of Manila, Makati City and Quezon were interviewed. T...

Full description

Saved in:
Bibliographic Details
Main Author: Lim, Cristina Teresa N.
Format: text
Published: Animo Repository 2012
Subjects:
Online Access:https://animorepository.dlsu.edu.ph/faculty_research/6716
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: De La Salle University
id oai:animorepository.dlsu.edu.ph:faculty_research-7505
record_format eprints
spelling oai:animorepository.dlsu.edu.ph:faculty_research-75052022-09-10T05:32:08Z Pharmaceuticals law management: Assessment of feasibility and effectiveness of the Universally Accessible Cheaper Medicines Act of 2008 Lim, Cristina Teresa N. The study aimed to assess if Republic Act No. 9502, otherwise known as Cheaper Medicines Act of 2008 has been adequately implemented in making cardiovascular medicines accessible and affordable in the Philippines. Sample respondents from the City of Manila, Makati City and Quezon were interviewed. These include pharmaceutical companies, pharmacists, cardiologists, internal medicine specialists, and out-patients from charity wards of selected public and private hospitals and drugstores were interviewed. Results of the study showed that after two years of the implementation of the Act, medicines are still expensive and branded medicines are still dispensed, prescribed and purchased more than medicines. Stakeholders have low level of perception of the Act resulting to non-compliance. They also believed that the Act is not strong enough to enforce generic prescription while patients are apprehensive of the effectiveness of generic medicines. Pharmaceutical companies experienced a decreased in the production output, thus, pharmaceutical companies were not encouraged to manufacture and offer for sale generic medicines. 2012-07-29T07:00:00Z text https://animorepository.dlsu.edu.ph/faculty_research/6716 Faculty Research Work Animo Repository Drugs—Prices—Law and legislation—Philippines Drugs—Generic substitution—Law and legislation—Philippines Philippines. Universally Accessible Cheaper Medicines Act of 2008 Medical Jurisprudence
institution De La Salle University
building De La Salle University Library
continent Asia
country Philippines
Philippines
content_provider De La Salle University Library
collection DLSU Institutional Repository
topic Drugs—Prices—Law and legislation—Philippines
Drugs—Generic substitution—Law and legislation—Philippines
Philippines. Universally Accessible Cheaper Medicines Act of 2008
Medical Jurisprudence
spellingShingle Drugs—Prices—Law and legislation—Philippines
Drugs—Generic substitution—Law and legislation—Philippines
Philippines. Universally Accessible Cheaper Medicines Act of 2008
Medical Jurisprudence
Lim, Cristina Teresa N.
Pharmaceuticals law management: Assessment of feasibility and effectiveness of the Universally Accessible Cheaper Medicines Act of 2008
description The study aimed to assess if Republic Act No. 9502, otherwise known as Cheaper Medicines Act of 2008 has been adequately implemented in making cardiovascular medicines accessible and affordable in the Philippines. Sample respondents from the City of Manila, Makati City and Quezon were interviewed. These include pharmaceutical companies, pharmacists, cardiologists, internal medicine specialists, and out-patients from charity wards of selected public and private hospitals and drugstores were interviewed. Results of the study showed that after two years of the implementation of the Act, medicines are still expensive and branded medicines are still dispensed, prescribed and purchased more than medicines. Stakeholders have low level of perception of the Act resulting to non-compliance. They also believed that the Act is not strong enough to enforce generic prescription while patients are apprehensive of the effectiveness of generic medicines. Pharmaceutical companies experienced a decreased in the production output, thus, pharmaceutical companies were not encouraged to manufacture and offer for sale generic medicines.
format text
author Lim, Cristina Teresa N.
author_facet Lim, Cristina Teresa N.
author_sort Lim, Cristina Teresa N.
title Pharmaceuticals law management: Assessment of feasibility and effectiveness of the Universally Accessible Cheaper Medicines Act of 2008
title_short Pharmaceuticals law management: Assessment of feasibility and effectiveness of the Universally Accessible Cheaper Medicines Act of 2008
title_full Pharmaceuticals law management: Assessment of feasibility and effectiveness of the Universally Accessible Cheaper Medicines Act of 2008
title_fullStr Pharmaceuticals law management: Assessment of feasibility and effectiveness of the Universally Accessible Cheaper Medicines Act of 2008
title_full_unstemmed Pharmaceuticals law management: Assessment of feasibility and effectiveness of the Universally Accessible Cheaper Medicines Act of 2008
title_sort pharmaceuticals law management: assessment of feasibility and effectiveness of the universally accessible cheaper medicines act of 2008
publisher Animo Repository
publishDate 2012
url https://animorepository.dlsu.edu.ph/faculty_research/6716
_version_ 1767196596784594944